DOSE FINDING STUDY OF PF-05212384 WITH PACLITAXEL AND CARBOPLATIN IN PATIENTS WITH ADVANCED SOLID TUMOR
Phase of Trial: Phase I
Latest Information Update: 10 Apr 2018
At a glance
- Drugs Gedatolisib (Primary) ; Carboplatin; Paclitaxel
- Indications Advanced breast cancer; Endometrial cancer; Head and neck cancer; Non-small cell lung cancer; Ovarian cancer; Small cell lung cancer
- Focus Adverse reactions
- 10 Apr 2018 Last checked against ClinicalTrials.gov record.
- 04 Apr 2018 Planned primary completion date changed from 1 Dec 2017 to 1 Dec 2019.
- 10 Jun 2017 Biomarkers information updated